Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment

References

• Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology.2000;23(2):138–50. doi:10.1016/S0893-133X(99)00158-X.
   PubMed Web of Science ®Google Scholar
• Highfield D, Yap J, Grimm JW, Shalev U, Shaham Y. Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats. Neuropsychopharmacology.2001;25(3):320–31. doi:10.1016/S0893-133X(01)00227-5.
   PubMed Web of Science ®Google Scholar
• Shaham Y, Highfield D, Delfs J, Leung S, Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci. 2000;12(1):292–302.doi:10.1046/j.1460-9568.2000.00899.x.
   PubMed Web of Science ®Google Scholar
• Jobes ML, Ghitza UE, Epstein DH, Phillips KA, Heishman SJ, Preston KL. Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology (Berl). 2011;218(1):83–88. doi:10.1007/s00213-011-2230-7.
   PubMed Web of Science ®Google Scholar
• Fox HC, Seo D, Tuit K, Hansen J, Kimmerling A, Morgan PT, Sinha R. Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings. J Psychopharmacol. 2012;26(7):958–72. doi:10.1177/0269881111430746.
   PubMed Web of Science ®Google Scholar
• Sinha R, Kimmerling A, Doebrick C, Kosten TR. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology (Berl). 2007;190(4):569–74. doi:10.1007/s00213-006-0640-8.
   PubMed Web of Science ®Google Scholar
• Kowalczyk WJ, Phillips KA, Jobes ML, Kennedy AP, Ghitza UE, Agage DA, Schmittner JP, Epstein DH, Preston KL. Clonidine maintenance prolongs opioid abstinence and decouples stress from craving in daily life: a randomized controlled trial with ecological momentary assessment. Am J Psychiatry. 2015;172(8):760–67. doi:10.1176/appi.ajp.2014.14081014.
   PubMed Web of Science ®Google Scholar
• De Maeyer J, Vanderplasschen W, Broekaert E. Quality of life among opiate-dependent individuals: a review of the literature. Int J Drug Policy. 2010;21(5):364–80. doi:10.1016/j.drugpo.2010.01.010.
   PubMed Web of Science ®Google Scholar
• Kosten TR, Morgan C, Kosten TA. Depressive symptoms during buprenorphine treatment of opioid abusers. J Subst Abuse Treat. 1990;7(1):51–54. doi:10.1016/0740-5472(90)90035-O.
   PubMed Web of Science ®Google Scholar
• Stein MD, Herman DS, Kettavong M, Cioe PA, Friedmann PD, Tellioglu T, Anderson BJ. Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons. J Subst Abuse Treat. 2010;39(2):157–66. doi:10.1016/j.jsat.2010.05.014.
   PubMed Web of Science ®Google Scholar
• Curran GM, Flynn HA, Kirchner J, Booth BM. Depression after alcohol treatment as a risk factor for relapse among male veterans. J Subst Abuse Treat. 2000;19(3):259–65. doi:10.1016/S0740-5472(00)00107-0.
   PubMed Web of Science ®Google Scholar
• Curran GM, Booth BM, Kirchner JE, Deneke DE. Recognition and management of depression in a substance use disorder treatment population. Am J Drug Alcohol Abuse. 2007;33(4):563–69. doi:10.1080/00952990701407496.
   PubMed Web of Science ®Google Scholar
• Levy MS. Listening to our clients: the prevention of relapse. J Psychoactive Drugs. 2008;40(2):167–72. doi:10.1080/02791072.2008.10400627.
   PubMed Web of Science ®Google Scholar
• Ramo DE, Brown SA. Classes of substance abuse relapse situations: a comparison of adolescents and adults. Psychol Addict Behav. 2008;22(3):372–79. doi:10.1037/0893-164X.22.3.372.
   PubMed Web of Science ®Google Scholar
• Shiffman S, Waters AJ. Negative affect and smoking lapses: a prospective analysis. J Consult Clin Psychol. 2004;72(2):192–201. doi:10.1037/0022-006X.72.2.192.
   PubMed Web of Science ®Google Scholar
• Bradley BP, Phillips G, Green L, Gossop M. Circumstances surrounding the initial lapse to opiate use following detoxification. Br J Psychiatry. 1989;154:354–59. doi:10.1192/bjp.154.3.354.
   PubMed Web of Science ®Google Scholar
• Marlatt GA, Gordon JR. Relapse prevention: maintenance strategies in addictive behavior change. New York: Guilford Press; 1985.
   Google Scholar
• Blum J, Gerber H, Gerhard U, Schmid O, Petitjean S, Riecher-Rössler A, Wiesbeck GA, Borgwardt SJ, Walter M. Acute effects of heroin on emotions in heroin-dependent patients. Am J Addict. 2013;22(6):598–604. doi:10.1111/ajad.v22.6.
   PubMed Web of Science ®Google Scholar
• Nummenmaa L, Tuominen L. Opioid system and human emotions. Br J Pharmacol. 2017; doi:10.1111/bph.13812.
   PubMed Web of Science ®Google Scholar
• Childress AR, Ehrman R, McLellan AT, MacRae J, Natale M, O’Brien CP. Can induced moods trigger drug-related responses in opiate abuse patients? J Subst Abuse Treat. 1994;11(1):17–23. doi:10.1016/0740-5472(94)90060-4.
   PubMed Web of Science ®Google Scholar
• Hyman SM, Fox H, Hong KI, Doebrick C, Sinha R. Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment. Exp Clin Psychopharmacol. 2007;15(2):134–43. doi:10.1037/1064-1297.15.2.134.
   PubMed Web of Science ®Google Scholar
• Powell J, Bradley B, Gray J. Classical conditioning and cognitive determinants of subjective craving for opiates: an investigation of their relative contributions. Br J Addict. 1992;87(8):1133–44. doi:10.1111/j.1360-0443.1992.tb02000.x.
   PubMedGoogle Scholar
• Weinstein A, Wilson S, Bailey J, Myles J, Nutt D. Imagery of craving in opiate addicts undergoing detoxification. Drug Alcohol Depend. 1997;48(1):25–31. doi:10.1016/S0376-8716(97)00098-7.
   PubMed Web of Science ®Google Scholar
• Toneatto T. A metacognitive analysis of craving: implications for treatment. J Clin Psychol. 1999;55(5):527–37. doi:10.1002/(ISSN)1097-4679.
   PubMed Web of Science ®Google Scholar
• Tiffany ST, Wray JM. The clinical significance of drug craving. Ann N Y Acad Sci. 2012;1248:1–17. doi:10.1111/j.1749-6632.2011.06298.x.
   PubMed Web of Science ®Google Scholar
• Greenwald MK, Johanson CE, Schuster CR. Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance. Drug Alcohol Depend. 1999;56(3):191–203. doi:10.1016/S0376-8716(99)00032-0.
   PubMed Web of Science ®Google Scholar
• Curran HV, Bolton J, Wanigaratne S, Smyth C. Additional methadone increases craving for heroin: a double-blind, placebo-controlled study of chronic opiate users receiving methadone substitution treatment. Addiction. 1999;94(5):665–74. doi:10.1046/j.1360-0443.1999.9456654.x.
   PubMed Web of Science ®Google Scholar
• Jaffe JH, Cascella NG, Kumor KM, Sherer MA. Cocaine-induced cocaine craving. Psychopharmacology (Berl). 1989;97(1):59–64. doi:10.1007/BF00443414.
   PubMed Web of Science ®Google Scholar
• Hammersley R. A digest of memory phenomena for addiction research. Addiction. 1994;89(3):283–93. doi:10.1111/add.1994.89.issue-3.
   PubMed Web of Science ®Google Scholar
• Bolger N, Laurenceau J-P. Intensive longitudinal methods. New York: Guilford; 2013.
   Google Scholar
• Van De Pol M, Wright J. A simple method for distinguishing within- versus between-subject effects using mixed models. Animal Behaviour. 2009;77:753–58. doi:10.1016/j.anbehav.2008.11.006.
   Web of Science ®Google Scholar
• Rosnow RL, Rosenthal R, Rubin DB. Contrasts and correlations in effect-size estimation. Psychol Sci. 2000;11(6):446–53. doi:10.1111/1467-9280.00287.
   PubMed Web of Science ®Google Scholar
• Preston KL, Epstein DH. Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology (Berl). 2011;218(1):29–37. doi:10.1007/s00213-011-2183-x.
   PubMed Web of Science ®Google Scholar
• Kamibayashi T, Maze M. Clinical uses of alpha2 -adrenergic agonists. Anesthesiology. 2000;93(5):1345–49. doi:10.1097/00000542-200011000-00030.
   PubMed Web of Science ®Google Scholar
• Kreibig SD. Autonomic nervous system activity in emotion: a review. Biol Psychol. 2010;84(3):394–421. doi:10.1016/j.biopsycho.2010.03.010.
   PubMed Web of Science ®Google Scholar
• Boehnlein JK, Kinzie JD. Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin. J Psychiatr Pract. 2007;13(2):72–78. doi:10.1097/01.pra.0000265763.79753.c1.
   PubMedGoogle Scholar
• Porter DM, Bell CC. The use of clonidine in post-traumatic stress disorder. J Natl Med Assoc. 1999;91(8):475–77.
   PubMed Web of Science ®Google Scholar
• Jasinski DR, Johnson RE, Kocher TR. Clonidine in morphine withdrawal. Differential effects on signs and symptoms. Arch Gen Psychiatry. 1985;42(11):1063–66. doi:10.1001/archpsyc.1985.01790340041006.
   PubMed Web of Science ®Google Scholar
• Charney DS, Heninger GR, Sternberg DE, Hafstad KM, Giddings S, Landis DH. Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects. Arch Gen Psychiatry. 1982;39(3):290–94. doi:10.1001/archpsyc.1982.04290030030005.
   PubMed Web of Science ®Google Scholar
• Siever LJ, Uhde TW. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine. Biol Psychiatry. 1984;19(2):131–56.
   PubMed Web of Science ®Google Scholar
• Dennison SJ. Clonidine abuse among opiate addicts. Psychiatr Q. 2001;72(2):191–95. doi:10.1023/A:1010375727768.
   PubMed Web of Science ®Google Scholar
• Beuger M, Tommasello A, Schwartz R, Clinton M. Clonidine use and abuse among methadone program applicants and patients. J Subst Abuse Treat. 1998;15(6):589–93. doi:10.1016/S0740-5472(97)00309-7.
   PubMed Web of Science ®Google Scholar
• Schaut J, Schnoll SH. Four cases of clonidine abuse. Am J Psychiatry. 1983;140(12):1625–27. doi:10.1176/ajp.140.12.1625.
   PubMed Web of Science ®Google Scholar
• Joshi W, Reuben SS, Kilaru PR, Sklar J, Maciolek H. Postoperative analgesia for outpatient arthroscopic knee surgery with intraarticular clonidine and/or morphine. Anesth Analg. 2000;90(5):1102–06. doi:10.1097/00000539-200005000-00018.
   PubMed Web of Science ®Google Scholar
• Spaulding TC, Fielding S, Venafro JJ, Lal H. Antinociceptive activity of clonidine and its potentiation of morphine analgesia. Eur J Pharmacol. 1979;58(1):19–25. doi:10.1016/0014-2999(79)90335-2.
   PubMed Web of Science ®Google Scholar
• Koppert W, Sittl R, Scheuber K, Alsheimer M, Schmelz M, Schuttler J. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology. 2003;99(1):152–59. doi:10.1097/00000542-200307000-00025.
   PubMed Web of Science ®Google Scholar
• Parsons JT, Kowalczyk WJ, Botsko M, Tomassilli J, Golub SA. Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men. AIDS and Behavior. 2013;17(4):1478–87. doi:10.1007/s10461-013-0463-7.
   PubMed Web of Science ®Google Scholar
• Trull TJ, Ebner-Priemer UW. Using experience sampling methods/ecological momentary assessment (ESM/EMA) in clinical assessment and clinical research: introduction to the special section. Psychol Assess. 2009;21(4):457–62. doi:10.1037/a0017653.
   PubMed Web of Science ®Google Scholar
• Bolt DM, Piper ME, Theobald WE, Baker TB. Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol. 2012;80(1):54–65. doi:10.1037/a0026366.
   PubMed Web of Science ®Google Scholar
• Kranzler HR, Armeli S, Feinn R, Tennen H, Gelernter J, Covault J. GRIK1 genotype moderates topiramate’s effects on daily drinking level, expectations of alcohol’s positive effects and desire to drink. Int J Neuropsychopharmacol. 2014;17(10):1549–56. doi:10.1017/S1461145714000510.
   PubMed Web of Science ®Google Scholar
• Kranzler HR, Armeli S, Wetherill R, Feinn R, Tennen H, Gelernter J, Covault J, Pond T. Self-efficacy mediates the effects of topiramate and GRIK1 genotype on drinking. Addict Biol. 2016;21(2):450–59. doi:10.1111/adb.12207.
   PubMed Web of Science ®Google Scholar
• Miranda R, MacKillop J, Treloar H, Blanchard A, Tidey JW, Swift RM, Chun T, Rohsenow DJ, Monti PM. Biobehavioral mechanisms of topiramate’s effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments. Addict Biol. 2016;21(1):171–82. doi:10.1111/adb.12192.
   PubMed Web of Science ®Google Scholar